Growth factors increase pericellular proteoglycans independently of their mitogenic effects on A10 rat vascular smooth muscle cells

Jackson, 1991, Glycosamino glycans: Molecular properties, protein interactions, and role in physiological processes, Physiol. Rev., 71, 481, 10.1152/physrev.1991.71.2.481

Ross, 1993, Atherosclerosis: A defence mechanism gone awry, Am. J. Pathol., 143, 987

Wight, 1989, Cell biology of arterial proteoglycans, Arteriosclerosis, 9, 1, 10.1161/01.ATV.9.1.1

Breton, 1986, Synthesis of sulfated proteoglycans throughout the cell cycle in smooth muscle cells from pig aorta, Exp. Cell Res., 166, 416, 10.1016/0014-4827(86)90487-8

Deudon, 1992, Growth-related production of proteoglycans and hyaluronic acid in synchronous arterial smooth muscle cells, Int. J. Biochem., 24, 465, 10.1016/0020-711X(92)90040-8

Hollmann, 1986, Increased activity of chondroitin sulfate-synthesizing enzymes during proliferation of arterial smooth muscle cells, Exp. Cell Res., 167, 484, 10.1016/0014-4827(86)90188-6

Schmidt, 1987, Proliferation-dependent changes of proteoglycan metabolism in arterial smooth muscle cells, Biol. Chem. Hoppe-Seyler, 368, 277, 10.1515/bchm3.1987.368.1.277

Skaletz-Rorowski, 1996, Heparin-induced overexpression of basic fibroblast growth factor, basic fibroblast growth factor receptor, and cell-associated proteoheparan sulfate in cultured coronary smooth muscle cells, Arterioscl. Thromb. Vasc. Biol., 16, 1063, 10.1161/01.ATV.16.8.1063

Williams, 1991, Modulation of proteoglycan synthesis by bovine vascular smooth muscle cells during cellular proliferation and treatment with heparin, Arch. Biochem. Biophys., 287, 386, 10.1016/0003-9861(91)90494-4

Arai, 1994, Glycosaminoglycans inhibit degradation of insulin-like growth factor binding protein-5, Endocrinology, 135, 2358, 10.1210/endo.135.6.7527332

Arai, 1994, Heparin, heparan sulfate, and dermatan sulfate regulate formation of the insulin-like growth factor-I and insulin-like growth factor-binding protein complexes., J. Biol. Chem., 269, 20388, 10.1016/S0021-9258(17)32004-5

Klagsbrun, 1991, A dual receptor system is required for basic fibroblast growth factor activity, Cell, 67, 229, 10.1016/0092-8674(91)90173-V

Parker, 1995, Properties of an insulin like growth factor binding protein 4 protease that is secreted by smooth muscle cells, Endocrinology, 135, 2470, 10.1210/endo.136.6.7538463

Rapraeger, 1991, Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation, Science, 252, 1705, 10.1126/science.1646484

Ruoslahti, 1991, Proteoglycans as modulators of growth factor activities, Cell, 64, 867, 10.1016/0092-8674(91)90308-L

Yayon, 1991, Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor, Cell, 64, 841, 10.1016/0092-8674(91)90512-W

Emoto, 1994, TSH increases cell surface heparan sulfate proteoglycans of FRTL-5 rat thyroid cells: A simple method for quantitatively estimating cell surface Demura sulfate proteoglycans, Endocrinol. Metab., 1, 123

Emoto, 1995, Degradation of cell surface heparan sulfates decreases the high affinity binding of basic FGF to endothelial cells, but not to FRTL-5 rat thyroid cells, Thyroid, 5, 455, 10.1089/thy.1995.5.455

Yanagishita, 1992, Cell surface heparan sulfate proteoglycans, J. Biol. Chem., 267, 9451, 10.1016/S0021-9258(19)50108-9

Thogersen, 1994, A quantitative method for analysis of radiolabelled proteoglycans synthesized by cultured human arterial smooth muscle cells, Int. J. Biochem., 26, 55, 10.1016/0020-711X(94)90195-3

Cizmeci-Smith, 1993, Differential expression of transmembrane proteoglycans in vascular smooth muscle cells, J. Biol. Chem., 268, 18740, 10.1016/S0021-9258(17)46692-0